Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I☆
To access this article, please choose from the options below
☆ Supported by grants from Medtronic, Inc (Minneapolis, Minn), the Muscular Dystrophy Association (Tucson, Ariz), and the National Institutes of Health (grant MO1-RR00750-27S1).
PII: S0002-8703(03)00636-7
doi:10.1016/j.ahj.2003.08.008
© 2004 Mosby, Inc. All rights reserved.
